Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2251 to 2265 of 7962 results

  1. Ensitrelvir for treating COVID-19 [ID6231]

    Awaiting development [GID-TA11224] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patients

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  3. Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]

    Awaiting development [GID-TA11494] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Vepdegestrant for treating hormone receptor-positive HER2-negative metastatic breast cancer after endocrine treatment [ID6360]

    In development [GID-TA11400] Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. Pembrolizumab with chemotherapy for treating platinum-resistant recurrent ovarian cancer after 1 or 2 treatments [ID6363]

    In development [GID-TA11422] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Lacosamide for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [ID1687]

    In development [GID-TA10664] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Tislelizumab with chemoradiation for treating localised oesophageal squamous cell cancer [ID5077]

    Awaiting development [GID-TA10971] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Cabozantinib with atezolizumab for treating hormone-relapsed metastatic prostate cancer after 1 hormonal treatment [ID6387]

    Awaiting development [GID-TA11438] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. MTEP - Routing Butterfly IQ ultrasound scanner MT635 (MIB254)

      Status ...

    Medical technologies guidance
    Topic selection

  10. PROPEL (mometasone furoate implant, 370ug) MT578 (MIB253)

      Status ...

    Medical technologies guidance
    Topic selection

  11. microINR for anticoagulation therapy MT592 (MIB257)

      Status ...

    Medical technologies guidance
    Topic selection

  12. Woundexpress MT602 (MIB261)

      Status ...

    Medical technologies guidance
    Topic selection

  13. Magtrace/Sentimag MT599 (MIB263)

      Status ...

    Medical technologies guidance
    Topic selection

  14. AI in retinal scanning MT524 (MIB265)

      Status ...

    Medical technologies guidance
    Topic selection

  15. Acumen IQ sensor MT616 (MIB266)

      Status ...

    Medical technologies guidance
    Topic selection